Skip Nav Destination
Issues
Clinical Care / Education / Nutrition
Randomized Controlled Trial of a New Dietary Education Program to Prevent Type 2 Diabetes in a High-Risk Group of Japanese Male Workers
Diabetes Care December 2003, Vol.26, 3209-3214. doi:https://doi.org/10.2337/diacare.26.12.3209
Cinnamon Improves Glucose and Lipids of People With Type 2 Diabetes
Alam Khan, MS, PHD; Mahpara Safdar, MS; Mohammad Muzaffar Ali Khan, MS, PHD; Khan Nawaz Khattak, MS; Richard A. Anderson, PHD
Diabetes Care December 2003, Vol.26, 3215-3218. doi:https://doi.org/10.2337/diacare.26.12.3215
Epidemiology / Health Services / Psychosocial Research
Adiponectin in a Native Canadian Population Experiencing Rapid Epidemiological Transition
Diabetes Care December 2003, Vol.26, 3219-3225. doi:https://doi.org/10.2337/diacare.26.12.3219
Plasma Adiponectin Is an Independent Predictor of Type 2 Diabetes in Asian Indians
Chamukuttan Snehalatha, MSC, DSC; Bheekamchand Mukesh, MBBS; Mary Simon, BSC; Vijay Viswanathan, MD, PHD; Steven M. Haffner, MD; Ambady Ramachandran, MD, PHD, FRCP
Diabetes Care December 2003, Vol.26, 3226-3229. doi:https://doi.org/10.2337/diacare.26.12.3226
The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity
Jaana Lindström, MSC; Anne Louheranta, PHD; Marjo Mannelin, MSC; Merja Rastas, MSC; Virpi Salminen, MSC; Johan Eriksson, MD, PHD; Matti Uusitupa, MD, PHD; Jaakko Tuomilehto, MD, PHD; for the Finnish Diabetes Prevention Study Group
Diabetes Care December 2003, Vol.26, 3230-3236. doi:https://doi.org/10.2337/diacare.26.12.3230
In Utero Dietary Exposures and Risk of Islet Autoimmunity in Children
Carolyn M. Fronczak, MSPH; Anna E. Barón, PHD; H. Peter Chase, MD; Colleen Ross, MS; Heather L. Brady, RD, MS; Michelle Hoffman, RN; George S. Eisenbarth, MD, PHD; Marian Rewers, MD, PHD; Jill M. Norris, MPH, PHD
Diabetes Care December 2003, Vol.26, 3237-3242. doi:https://doi.org/10.2337/diacare.26.12.3237
Premenopausal Advantages in Postprandial Lipid Metabolism Are Lost in Women With Type 2 Diabetes
Michael G. Masding, MBBS, MRCP; Anna J. Stears, MBBS, MRCP; Graham C. Burdge, PHD; Stephen A. Wootton, PHD; Derek D. Sandeman, BSC, MBBS, FRCP
Diabetes Care December 2003, Vol.26, 3243-3249. doi:https://doi.org/10.2337/diacare.26.12.3243
Racial Variation in the Control of Diabetes Among Elderly Medicare Managed Care Beneficiaries
A. Marshall McBean, MD, MSC; Zhen Huang, MS; Beth A. Virnig, PHD, MPH; Nicole Lurie, MD, MSPH; Dorothea Musgrave, MPH
Diabetes Care December 2003, Vol.26, 3250-3256. doi:https://doi.org/10.2337/diacare.26.12.3250
Diabetes Is Associated With Subclinical Functional Limitation in Nondisabled Older Individuals: The Health, Aging, and Body Composition study
Nathalie de Rekeneire, MD; Helaine E. Resnick, PHD; Ann V. Schwartz, PHD; Ronald I. Shorr, MD, MS; Lewis H. Kuller, MD, DRPH; Eleanor M. Simonsick, PHD; Bruno Vellas, PHD; Tamara B. Harris, MD, MS
Diabetes Care December 2003, Vol.26, 3257-3263. doi:https://doi.org/10.2337/diacare.26.12.3257
Emerging Treatments and Technologies
Primary Prevention of Cardiovascular Events With Low-Dose Aspirin and Vitamin E in Type 2 Diabetic Patients: Results of the Primary Prevention Project (PPP) trial
Michele Sacco, MD; Fabio Pellegrini, MS; Maria C. Roncaglioni, MSC, BIOLS; Fausto Avanzini, MD; Gianni Tognoni, MD; Antonio Nicolucci, MD; on behalf of the PPP Collaborative Group
Diabetes Care December 2003, Vol.26, 3264-3272. doi:https://doi.org/10.2337/diacare.26.12.3264
The Combined Effect of Triple Therapy With Rosiglitazone, Metformin, and Insulin Aspart in Type 2 Diabetic Patients
Mikael Kjær Poulsen, MD; Jan Erik Henriksen, MD, PHD; Ole Hother-Nielsen, MD, MSCI; Henning Beck-Nielsen, MD, MSCI
Diabetes Care December 2003, Vol.26, 3273-3279. doi:https://doi.org/10.2337/diacare.26.12.3273
Enhancing Sensation in Diabetic Neuropathic Foot With Mechanical Noise
Lalita Khaodhiar, MD; James B. Niemi, MS; Russell Earnest, DPM; Christina Lima, BA; Jason D. Harry, PHD; Aristidis Veves, MD
Diabetes Care December 2003, Vol.26, 3280-3283. doi:https://doi.org/10.2337/diacare.26.12.3280
Clinical Efficacy of the First Metatarsophalangeal Joint Arthroplasty as a Curative Procedure for Hallux Interphalangeal Joint Wounds in Patients with Diabetes
David G. Armstrong, DPM, MSC; Lawrence A. Lavery, DPM, MPH; Jefferey R. Vazquez, DPM; Brian Short, DPM; Heather R. Kimbriel, BA; Brent P. Nixon, DPM, MBA; Andrew J.M. Boulton, MD
Diabetes Care December 2003, Vol.26, 3284-3287. doi:https://doi.org/10.2337/diacare.26.12.3284
Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression: The National Institutes of Health experience
Boaz Hirshberg, MD; Kristina I. Rother, MD; Benigno J. Digon, III, MD; Janet Lee, MD; Jason L. Gaglia, MD; Kenneth Hines, BS, MT (ASCP); Elizabeth J. Read, MD; Richard Chang, MD; Bradford J. Wood, MD; David M. Harlan, MD
Diabetes Care December 2003, Vol.26, 3288-3295. doi:https://doi.org/10.2337/diacare.26.12.3288
Pathophysiology / Complications
Kidney Function During and After Withdrawal of Long-Term Irbesartan Treatment in Patients With Type 2 Diabetes and Microalbuminuria
Steen Andersen, MD; Jens Bröchner-Mortensen, MD, DMSC; Hans-Henrik Parving, MD, DMSC; Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria Study Group
Diabetes Care December 2003, Vol.26, 3296-3302. doi:https://doi.org/10.2337/diacare.26.12.3296
Contribution of Visceral Adiposity to the Exaggerated Postprandial Lipemia of Men With Impaired Glucose Tolerance
Patricia Blackburn, MSC; Benoît Lamarche, PHD; Charles Couillard, PHD; Agnés Pascot, PHD; Angelo Tremblay, PHD; Jean Bergeron, MD, MSC; Isabelle Lemieux, PHD; Jean-Pierre Després, PHD, FAHA
Diabetes Care December 2003, Vol.26, 3303-3309. doi:https://doi.org/10.2337/diacare.26.12.3303
Insulin Suppresses Plasma Concentration of Vascular Endothelial Growth Factor and Matrix Metalloproteinase-9
Paresh Dandona, MD, DPHIL, FRCP; Ahmad Aljada, PHD; Priya Mohanty, MD; Husam Ghanim, BS; Arindam Bandyopadhyay, MD; Ajay Chaudhuri, MBBS, MRCP
Diabetes Care December 2003, Vol.26, 3310-3314. doi:https://doi.org/10.2337/diacare.26.12.3310
Plasma Adiponectin and Endogenous Glucose Production in Humans
Norbert Stefan, MD; Michael Stumvoll, MD; Barbora Vozarova, MD; Christian Weyer, MD; Tohru Funahashi, MD, PHD; Yuji Matsuzawa, MD, PHD; Clifton Bogardus, MD; P. Antonio Tataranni, MD
Diabetes Care December 2003, Vol.26, 3315-3319. doi:https://doi.org/10.2337/diacare.26.12.3315
Metabolic Syndrome / Insulin Resistance / Pre-Diabetes
Diagnosing Insulin Resistance by Simple Quantitative Methods in Subjects With Normal Glucose Metabolism
Juan F. Ascaso, MD; Susana Pardo, MD; José T. Real, MD; Rosario I. Lorente, MD; Antonia Priego, MD; Rafael Carmena, MD
Diabetes Care December 2003, Vol.26, 3320-3325. doi:https://doi.org/10.2337/diacare.26.12.3320
Reviews / Commentaries / Position Statements
Why Can’t We Prevent Type 1 Diabetes?: Maybe it’s time to try a different combination
Diabetes Care December 2003, Vol.26, 3326-3328. doi:https://doi.org/10.2337/diacare.26.12.3326
Lowering the Criterion for Impaired Fasting Glucose Will Not Provide Clinical Benefit
Diabetes Care December 2003, Vol.26, 3329-3330. doi:https://doi.org/10.2337/diacare.26.12.3329
Lowering the Criterion for Impaired Fasting Glucose Is in Order
Diabetes Care December 2003, Vol.26, 3331-3332. doi:https://doi.org/10.2337/diacare.26.12.3331
Editorial
Aspirin for Primary Prevention of Cardiovascular Events in Diabetes
Diabetes Care December 2003, Vol.26, 3349-3350. doi:https://doi.org/10.2337/diacare.26.12.3349
Letters: Observations
Nonalcoholic Fatty Liver Disease in Saudi Type 2 Diabetic Subjects Attending a Medical Outpatient Clinic: Prevalence and general characteristics
Diabetes Care December 2003, Vol.26, 3351-3352. doi:https://doi.org/10.2337/diacare.26.12.3351-a
Prospective Audit of the Introduction of Insulin Glargine (Lantus) Into Clinical Practice in Type 1 Diabetic Patients
Diabetes Care December 2003, Vol.26, 3352-3353. doi:https://doi.org/10.2337/diacare.26.12.3352
Self-Blood Glucose Monitoring Practices: Do patients know and act on their target?
Deb K. Bjorsness, MPH, RD, CDE; Philip A. Krezowski, MD; Todd S. Harwell, MPH; Janet M. McDowall, RN, BSN; Marcene K. Butcher, RD, CDE; Steven D. Helgerson, MD, MPH; Dorothy Gohdes, MD
Diabetes Care December 2003, Vol.26, 3353-3354. doi:https://doi.org/10.2337/diacare.26.12.3353
The Cutoff Value of Fasting Plasma Glucose to Differentiate Frequencies of Cardiovascular Risk Factors in a Korean Population
Dong-Jun Kim, MD; Kwang-Won Kim, MD, PHD; Nam-Han Cho, MD, PHD; Jung-Hyun Noh, MD, PHD; Myung-Shik Lee, MD, PHD; Moon-Kyu Lee, MD, PHD
Diabetes Care December 2003, Vol.26, 3354-3356. doi:https://doi.org/10.2337/diacare.26.12.3354
Safety Issues on Metformin Use
Diabetes Care December 2003, Vol.26, 3356-3357. doi:https://doi.org/10.2337/diacare.26.12.3356
High Prevalence of Peripheral Arterial Disease but Low Antiplatelet Treatment Rates in Elderly Primary Care Patients With Diabetes
Stefan Lange, MD; Curt Diehm, MD, PHD; Harald Darius, MD, PHD; Roman Haberl, MD, PHD; Jens Rainer Allenberg, MD, PHD; David Pittrow, MD; Alexander Schuster, MD; Berndt von Stritzky, MD; Gerhart Tepohl, MD; Hans Joachim Trampisch, PHD
Diabetes Care December 2003, Vol.26, 3357-3358. doi:https://doi.org/10.2337/diacare.26.12.3357
Patient and Provider Congruence
Diabetes Care December 2003, Vol.26, 3358. doi:https://doi.org/10.2337/diacare.26.12.3358
Maturity-Onset Diabetes of the Young (MODY) Mutation in Type 2 Diabetes and Latent Autoimmune Diabetes of the Adult
James McKinney, BSC; Henian Cao, MD; Margaret T. Behme, PHD; Jeffrey L. Mahon, MD; Robert A. Hegele, MD
Diabetes Care December 2003, Vol.26, 3358-3359. doi:https://doi.org/10.2337/diacare.26.12.3358-a
It Can Be Done
Diabetes Care December 2003, Vol.26, 3359-3360. doi:https://doi.org/10.2337/diacare.26.12.3359
Letters: Comments and Responses
Glimepiride and Serum Adiponectin Level in Type 2 Diabetic Subjects: Response to Nagasaka et al.
Diabetes Care December 2003, Vol.26, 3360-3361. doi:https://doi.org/10.2337/diacare.26.12.3360
Glimepiride and Serum Adiponectin Level in Type 2 Diabetic Subjects: Response to Yoshioka, Yoshida, and Yoshikawa
Shoichiro Nagasaka, MD; Ataru Taniguchi, MD; Yoshitaka Aiso, MD; Toshimitsu Yatagai, MD; Tomoatsu Nakamura, MD; Yoshikatsu Nakai, MD; Mitsuo Fukushima, MD; Akira Kuroe, MD; Shun Ishibashi, MD
Diabetes Care December 2003, Vol.26, 3361. doi:https://doi.org/10.2337/diacare.26.12.3361
Comparison of Repaglinide and Nateglinide in Combination With Metformin: Response to Raskin et al.
Diabetes Care December 2003, Vol.26, 3361-3362. doi:https://doi.org/10.2337/diacare.26.12.3361-a
Comparison of Repaglinide and Nateglinide in Combination With Metformin: Response to Baron
Diabetes Care December 2003, Vol.26, 3362-3363. doi:https://doi.org/10.2337/diacare.26.12.3362
Meta-Analysis of Low–Glycemic Index Diets in the Management of Diabetes: Response to Franz
Diabetes Care December 2003, Vol.26, 3363-3364. doi:https://doi.org/10.2337/diacare.26.12.3363
Meta-Analysis of Low-Glycemic Index Diets in the Management of Diabetes: Response to Franz
Diabetes Care December 2003, Vol.26, 3364. doi:https://doi.org/10.2337/diacare.26.12.3364
Meta-Analysis of Low-Glycemic Index Diets in the Management of Diabetes: Response to Brand-Miller et al. and Mann
Diabetes Care December 2003, Vol.26, 3364-3365. doi:https://doi.org/10.2337/diacare.26.12.3364-a
